MiNK Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: MiNK Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
MiNK Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $7.37M, a 1.16% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$7.37M	-$86.9K	-1.16%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$10.3M	-$1.79M	-14.8%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$6.89M	-$9.69M	-58.4%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$4.55M	-$16.9M	-78.8%	Dec 31, 2023	10-Q	2024-11-14
Q3 2023	$7.46M	-$17.8M	-70.5%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$12.1M	-$19M	-61.1%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$16.6M	-$19.6M	-54.1%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$21.5M	-$18.8M	-46.6%	Dec 31, 2022	10-K	2024-03-21
Q3 2022	$25.3M	+$21.2M	+520%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$31.1M			Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$36.1M			Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$40.2M	+$35.7M	+783%	Dec 31, 2021	10-K	2023-03-24
Q3 2021	$4.08M			Sep 30, 2021	10-Q	2021-11-29
Q4 2020	$4.56M			Dec 31, 2020	10-K	2022-03-18

* An asterisk sign (*) next to the value indicates that the value is likely invalid.